The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.


Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
12 2020
Historique:
received: 14 07 2020
revised: 25 08 2020
accepted: 30 09 2020
pubmed: 4 11 2020
medline: 5 8 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

Myeloproliferative neoplasms (MPNs) are characterized by significant symptom burden. Integrative medicine (IM) offers unique symptom management strategies. This study describes IM interventions utilized by MPN patients and the association with symptom burden, quality of life, depression, and fatigue adjusted for lifestyle confounders. MPN patients were surveyed online for IM utilization, MPN symptom burden (MPN-Symptom Assessment Form Total Symptom Score), depression (Patient Health Questionnaire), fatigue (Brief Fatigue Inventory), and a single question on overall quality of life. Measures were compared by IM participation and adjusted for alcohol and tobacco use, BMI, diet, and MPN type using multiple linear and logistic regression. A total of 858 participants were included in the analysis. Aerobic activity (p =< 0.001) and strength training (p = 0.01) were associated with lower mean symptom burden while massage (p =< 0.001) and support groups (p =< 0.001) were associated with higher levels of symptom burden. Higher quality of life was reported in massage (p = 0.04) and support groups (p = 0.002) while lower quality of life was noted in aerobic activity (p =< 0.001) and strength training (p = 0.001). A lower depression screening score was noted in those participating in aerobic activity (p = 0.006), yoga (p = 0.03), and strength training (p = 0.02). Lower fatigue was noted in those participating in aerobic activity (p =< 0.001) and strength training (p = 0.03) while higher fatigue was noted in those participating in massage (p =< 0.001) and breathing techniques (p = 0.02). Data available on request from the authors. This international survey of MPN patients on IM usage, has shown that patients who participated in a form of IM had a pattern of decreased levels of symptom burden, fatigue, depression, and higher QoL, as adjusted for health lifestyle practices overall.

Identifiants

pubmed: 33140580
doi: 10.1002/cam4.3566
pmc: PMC7774715
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9445-9453

Informations de copyright

© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

Psychosomatics. 2018 Sep - Oct;59(5):472-480
pubmed: 29506868
N Engl J Med. 2012 Mar 1;366(9):787-98
pubmed: 22375970
Leuk Lymphoma. 2015 Jul;56(7):1989-99
pubmed: 25644746
Am J Hematol. 2016 Dec;91(12):1262-1271
pubmed: 27870387
J Hematol Oncol. 2017 Feb 22;10(1):55
pubmed: 28228106
Semin Thromb Hemost. 2019 Sep;45(6):604-611
pubmed: 31382304
Cancer. 2007 Jan 1;109(1):68-76
pubmed: 17123268
Rev Med Chil. 2016 Jul;144(7):894-9
pubmed: 27661552
Curr Hematol Malig Rep. 2019 Jun;14(3):164-170
pubmed: 31093888
J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):
pubmed: 29140485
Blood. 2011 Jul 14;118(2):401-8
pubmed: 21536863
N Engl J Med. 2015 Apr 23;372(17):1670-1
pubmed: 25901432
Eur J Oncol Nurs. 2019 Feb;38:36-41
pubmed: 30717934
J Clin Oncol. 2011 Feb 20;29(6):761-70
pubmed: 21205761
Am J Hematol. 2017 Jan;92(1):94-108
pubmed: 27991718
Leuk Lymphoma. 2019 Feb;60(2):402-408
pubmed: 30033837
Curr Hematol Malig Rep. 2019 Aug;14(4):328-336
pubmed: 31209644
Integr Cancer Ther. 2017 Dec;16(4):439-450
pubmed: 27458250
J Natl Compr Canc Netw. 2016 Dec;14(12):1563-1570
pubmed: 27956541
Cancer. 2016 Feb 1;122(3):477-85
pubmed: 26670597
Cancer Cell. 2005 Apr;7(4):387-97
pubmed: 15837627
Curr Hematol Malig Rep. 2019 Oct;14(5):460-468
pubmed: 31372878
J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):
pubmed: 29140493
Psychooncology. 2019 Apr;28(4):896-902
pubmed: 30803097
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Clin Epidemiol. 2018 Dec 18;11:23-33
pubmed: 30588121

Auteurs

Krisstina Gowin (K)

Department of Hematology, University of Arizona, Tucson, AZ, USA.

Blake T Langlais (BT)

Department of Biostatistics, Mayo Clinic, Phoenix, Phoenix, AZ, USA.

Heidi E Kosiorek (HE)

Department of Biostatistics, Mayo Clinic, Phoenix, Phoenix, AZ, USA.

Amylou Dueck (A)

Department of Biostatistics, Mayo Clinic, Phoenix, Phoenix, AZ, USA.

Denise Millstine (D)

Integrative Medicine Program, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA.

Jennifer Huberty (J)

School of Nutrition and Health Promotion, Arizona State University, Phoenix, AZ, USA.

Ryan Eckert (R)

Mays Cancer Center, University of Texas, San Antonio, TX, USA.

Ruben A Mesa (RA)

Mays Cancer Center, University of Texas, San Antonio, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH